NASD | Health Care | Biotechnology

Zentalis Pharmaceuticals LLC (ZNTL)

LAST (2 Apr, 10:32 AM ET)
1.37
-0.02  (-1.44%)
Extended HOURS (00:00 PM ET)
-
-  (+000.00%)
MARKET CAP
97.625 M
VOLUME
147,900
ENTER A SYMBOL
MEMBER ACTIONS
Summary as of: 2 Apr, 10:32 AM ET
Open 1.34
Previous Close 1.39
Day Range 1.34 - 1.41
52-Week Range 1.36 - 16.26
All-Time High 87.19
Avg. Volume (50-day) 1,685,577.9
EPS (TTM) -2.33
Next Earnings Date 2025-05-07 (AMC)
Last Earnings Date 2025-03-26
Forward Annual Dividend (Yield) -
Trailing Annual Dividend (Yield) -
Options Yes
Fundamentals
P/E Ratio -0.60
PEG Ratio -
Price to Book 0.29
Price to Cash Flow -
Price to Free Cash Flow -
Total Sales (TTM) 67.42 M
Revenue per Share (TTM) 0.95
Shares Outstanding 71.811 M
Share Float (%) 54.00 M (75.19%)
% Held by Institutions 86.97
Dividends Per Share (TTM) -
Ex-Dividend Date -
Technicals
+/- EMA(20) 1.78 (-23.03%)
+/- SMA(50) 1.99 (-31.16%)
+/- SMA(200) 3.14 (-56.37%)
5-Day Perf. -22.16%
1-Month Perf. -33.82%
3-Month Perf. -54.33%
6-Month Perf. -59.1%
YTD Perf. -54.79%
1-Year Perf. -90.51%
RSI(14) 30.44
ATR(14) 0.18
ADX(14) 15.5
Beta (5Y) 1.43
Earnings NEW

FOR STOCKCHARTS MEMBERS ONLY

Unlock earnings and revenue history when you join StockCharts

As a StockCharts Member, you can review earnings results and analyze revenue and earnings growth over time. Bring a balance of technicals and fundamentals to your approach when you join today!

SCTR Rank SCTR Reports  

ZNTL

7.1
(-0.3)
SCTR Universe: Small Cap
Click Here for more info about the StockCharts Technical Rankings (SCTRs)
Profile

Zentalis Pharmaceuticals LLC

10275 Science Center Drive, Suite 200
San Diego, California
http://www.zentalis.com
Sector: Health Care
Industry: Biotechnology
Employees: 166
Description

Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations. The company was founded by Kevin D. Bunker and Cam Gallagher on December 23, 2014 and is headquartered in San Diego, CA.

Predefined Scans with ZNTL View All  
Alerts for ZNTL View All   New

FOR STOCKCHARTS MEMBERS ONLY

Unlock custom technical alerts when you join StockCharts

As a StockCharts Member, you can create your own unique alerts with the technical criteria that matters most to you. Stay ahead of important moves and never miss a thing in the markets.

ChartLists with ZNTL

FOR STOCKCHARTS MEMBERS ONLY

Unlock ChartLists to save and organize your charts when you join StockCharts

As a StockCharts Member, you can save the charts you're watching to your own account with ChartLists. Accessible from any device, you can organize, review and analyze your charts on-the-go, anytime, anywhere.